Perturbation of the human microbiome as a contributor to inflammatory bowel disease

Area of Science:

• Microbiome research
• Immunology
• Gastroenterology

Background:

• The human microbiome, comprising native flora with vast genetic material, is vital for health.
• A balanced microbiome prevents illness, including autoimmune conditions like inflammatory bowel disease (IBD).
• IBD, encompassing Crohn's disease (CD) and ulcerative colitis (UC), causes significant suffering and healthcare costs.

Purpose of the Study:

• To review the role of microbiome disruption in immune dysregulation and IBD pathogenesis.
• To summarize the importance of microbiome diversity and function in maintaining health.
• To explore emerging therapeutic strategies targeting microbiome-host interactions for IBD.

Main Methods:

• Literature review of current research on the human microbiome and IBD.
• Analysis of studies investigating the link between microbial dysbiosis and immune responses.
• Synthesis of information on therapeutic interventions for IBD based on microbiome modulation.

Main Results:

• Disruption of a normal microbiome is implicated as a cause of immune dysregulation and IBD initiation.
• Microbiome diversity and specific functional elements are critical for host health.
• Various therapeutic approaches modulating the microbiome are under investigation for IBD treatment.

Conclusions:

• Restoring or maintaining a healthy microbiome is a promising avenue for IBD prevention and treatment.
• Understanding microbiome-host interactions offers potential for novel therapeutic strategies.
• Further research into microbiome-based therapies could significantly impact IBD management.